Business of Cannabis Europe
OCT Announces Potential New ‘First In Class’ Immunotherapy Treatment, Kanabo Stock Jumps On New Deal, Intercure Leaves TSX
Oxford Cannabinoid Technologies Oxford Cannabinoid Technologies announced this week that it had identified a potential ‘first in class’ immunotherapy
Ben Stevens
July 20, 2023
